trial
as of 2026-07-01Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
NCTId NCT00552500
at a glance
— · Completed
Enrollment 120 (estimated)
Sponsored by Washington University School of Medicine
Primary completion 2005-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2003-02
Primary completion
2005-12
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
Washington University School of MedicineLead Sponsor
Investigators
1
Daniel W Haupt, MDPrincipal Investigator
Sites
1 total
St Louis, United States
Facts & assertions
4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2005-12
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person